<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inherited <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> such as protein C, protein S, and <z:hpo ids='HP_0001976'>antithrombin III deficiencies</z:hpo> account for 15% to 20% of recurrent thromboembolic episodes </plain></SENT>
<SENT sid="1" pm="."><plain>A common risk profile is associated with these disorders and guides the use of laboratory screening </plain></SENT>
<SENT sid="2" pm="."><plain>The use of <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> in inherited <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> varies with a patient's personal and familial history of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Special consideration is given to the need for <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> perioperatively and during pregnancy </plain></SENT>
</text></document>